POTENTIAL ANTITUMOR AGENTS .62. STRUCTURE-ACTIVITY-RELATIONSHIPS FOR TRICYCLIC COMPOUNDS RELATED TO THE COLON-TUMOR ACTIVE-DRUG 9-OXO-9H-XANTHENE-4-ACETIC ACID

被引:49
作者
REWCASTLE, GW
ATWELL, GJ
PALMER, BD
BOYD, PDW
BAGULEY, BC
DENNY, WA
机构
[1] UNIV AUCKLAND,SCH MED,CANC RES LAB,AUCKLAND,NEW ZEALAND
[2] UNIV AUCKLAND,DEPT CHEM,AUCKLAND,NEW ZEALAND
关键词
D O I
10.1021/jm00106a003
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of tricyclic analogues of 9-oxo-9H-xanthene-4-acetic acid have been prepared and evaluated for their ability to cause hemorrhagic necrosis in subcutaneously implanted colon 38 tumors in mice, in an effort to extend the structure-activity relationships for this series. As was found previously with analogues of flavone-8-acetic acid (FAA) (Atwell et al. Anti-Cancer Drug Des. 1989, 4, 161), all electronic modifications of the XAA nucleus led to severe decreases or complete abolition of activity, suggesting narrow structure-activity relationships. Dipole moments for many of the compounds were computed, and the degree to which the molecular dipole moment lay out of the plane of the aromatic part of these molecules was found to be determined largely by the contributions from the acetic acid moiety relative to that from the tricyclic ring system. There did not appear to be any general relationship between the magnitude of the dipole moment and activity. However, for compounds containing the 9-carbonyl functionality, the orientation of the dipole vector may be of significance. In all compounds possessing an ether group peri to the acetic acid side chain, there was a close approach (ca. 2.4 angstrom) between this and the side chain OH.
引用
收藏
页码:491 / 496
页数:6
相关论文
共 40 条
[1]   The disalicyl acid or anhydro-salicyl acid and its conversion to xanthon-4-carboxylic acid. [J].
Anschutz, R ;
Claasen, W .
BERICHTE DER DEUTSCHEN CHEMISCHEN GESELLSCHAFT, 1922, 55 :680-689
[2]  
ATASSI G, 1985, EUR J MED CHEM, V20, P393
[3]   POTENTIAL ANTITUMOR AGENTS .60. RELATIONSHIPS BETWEEN STRUCTURE AND INVIVO COLON 38 ACTIVITY FOR 5-SUBSTITUTED 9-OXOXANTHENE-4-ACETIC ACIDS [J].
ATWELL, GJ ;
REWCASTLE, GW ;
BAGULEY, BC ;
DENNY, WA .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (05) :1375-1379
[4]  
ATWELL GJ, 1989, ANTI-CANCER DRUG DES, V4, P161
[5]   COMPARISON OF THE EFFECTS OF FLAVONE ACETIC-ACID, FOSTRIECIN, HOMOHARRINGTONINE AND TUMOR NECROSIS FACTOR-ALPHA ON COLON-38 TUMORS IN MICE [J].
BAGULEY, BC ;
CALVELEY, SB ;
CROWE, KK ;
FRAY, LM ;
OROURKE, SA ;
SMITH, GP .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (02) :263-269
[6]   CRYSTAL AND MOLECULAR-STRUCTURE OF DIBENZOFURAN [J].
BANERJEE, A .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1973, 29 (OCT15) :2070-2074
[7]   REDUCTION OF TUMOR BLOOD-FLOW BY FLAVONE ACETIC-ACID - A POSSIBLE COMPONENT OF THERAPY [J].
BIBBY, MC ;
DOUBLE, JA ;
LOADMAN, PM ;
DUKE, CV .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (03) :216-222
[8]  
BISWAS SC, 1982, INDIAN J PURE AP PHY, V20, P414
[9]  
BISWAS SC, 1969, INDIAN J PURE AP PHY, V7, P408
[10]  
Briet P, 1989, European Patent Register, Patent No. [EP0341104, 0341104]